Cigna Group
CI Healthcare Healthcare Plans
Cigna Group’s revenue for fiscal 2025 (year ended December 2025) was $274.9 billion, up 11.2% from fiscal 2024. In the quarter to June 2026, revenue grew 6.68%, EPS grew 10.2%, free cash flow grew 66.9% and total debt rose 3.61%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for ten; insiders bought in the last twelve months.
Follow CI
Cigna Group (CI) P/S ratio
As of 16 October 2026, Cigna Group (CI) trades at a P/S ratio of 0.3×. Over the past ten years it has ranged from 0.2× (October 2025) to 1.4× (January 2018); the current reading is higher than 8% of that period. That is below the Healthcare Plans industry median of 0.4× and below the Healthcare sector median of 3.4×.
P/S ratio, daily
Embed this chart
Annual newest first
| Period | P/S ratio | Change |
|---|---|---|
| FY2025 | 0.3× | (14.72%) |
| FY2024 | 0.3× | (32.89%) |
| FY2023 | 0.5× | (15.35%) |
| FY2022 | 0.6× | 23.67% |
| FY2021 | 0.4× | (5.89%) |
| FY2020 | 0.5× | (5.37%) |
| FY2019 | 0.5× | (48.01%) |
| FY2018 | 1.0× | (20.79%) |
| FY2017 | 1.2× | 39.72% |
| FY2016 | 0.9× | (12.09%) |
Quarterly newest first
| Period | P/S ratio | Change |
|---|---|---|
| Jun 2026 | 0.3× | 1.78% |
| Mar 2026 | 0.3× | (5.58%) |
| Dec 2025 | 0.3× | (6.58%) |
| Sep 2025 | 0.3× | (14.86%) |
| 42 more quarters | Free account |
Against its own ten years
P/S ratio against peers
| Company | P/S ratio |
|---|---|
| CNC Centene Corporation compare | 0.2× |
| MOH Molina Healthcare, Inc compare | 0.2× |
| CI Cigna Group | 0.3× |
| CVS CVS Health Corporation compare | 0.3× |
| HUM Humana Inc. compare | 0.3× |
| ELV Elevance Health, Inc. compare | 0.5× |
| OSCR Oscar Health, Inc. compare | 0.6× |
| UNH UnitedHealth Group Incorporated compare | 0.8× |
| CLOV Clover Health Investments, Corp. compare | 0.9× |
| Healthcare Plans industry median | 0.4× |
| Healthcare sector median | 3.4× |
| Market median | 1.9× |
What P/S ratio is
Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.
(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)
More on CI
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement